相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa
K. Steegen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa
Ruth L. Goodall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa
Gillian M. Hunt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study
John Gregson et al.
LANCET INFECTIOUS DISEASES (2017)
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
Laura Ciaffi et al.
LANCET HIV (2017)
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
Soo-Yon Rhee et al.
EBIOMEDICINE (2017)
Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa
Ujjwal Neogi et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
Genotypic HIV-1 Drug Resistance Among Patients Failing Tenofovir-Based First-Line HAART in South India
Thongadi Ramesh Dinesha et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study
Edward P. Lam et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa
T. Sonia Boender et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
John Gregson et al.
LANCET INFECTIOUS DISEASES (2016)
Lamivudine Monotherapy Experience of Medium-term Outcomes in HIV-infected Children Unable to Adhere to Triple Therapy
Verena Linder et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda
Jean d'Amour Ndahimana et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2016)
Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya
Katherine Brooks et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2016)
Increased Virological Failure in Naive HIV-1-Infected Patients Taking Lamivudine Compared With Emtricitabine in Combination With Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort
Casper Rokx et al.
CLINICAL INFECTIOUS DISEASES (2015)
High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa
Lindiwe Skhosana et al.
PLOS ONE (2015)
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
Pontiano Kaleebu et al.
PLOS ONE (2015)
Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
Ujjwal Neogi et al.
PLOS ONE (2014)
HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia
Awachana Jiamsakul et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy
Mary-Ann A. Etiebet et al.
AIDS (2013)
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir
K. Theys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa
Christopher J. Hoffmann et al.
ANTIVIRAL THERAPY (2013)
Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens
Gert U. Van Zyl et al.
PLOS ONE (2013)
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen
Henry Sunpath et al.
AIDS (2012)
Virological Response and HIV Drug Resistance 12 Months After Antiretroviral Therapy Initiation at 2 Clinics in Nigeria
Richard Ugbena et al.
CLINICAL INFECTIOUS DISEASES (2012)
HIV-1 Amino Acid Changes Among Participants With Virologic Failure: Associations With First-line Efavirenz or Atazanavir Plus Ritonavir and Disease Status
Katie Mollan et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up
Paz Sobrino-Vegas et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2011)
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa
Kim C. E. Sigaloff et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus
HimaBindu Chunduri et al.
VIROLOGY JOURNAL (2011)
Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays
Ravindra K. Gupta et al.
AIDS (2010)
Antiretroviral combinations implicated in emergence of the L741 and L74V resistance mutations in HIV-1-infected patients
Marc Wirden et al.
AIDS (2009)
In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine
Roger Paredes et al.
JOURNAL OF VIROLOGY (2009)
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis
Ravindra K. Gupta et al.
LANCET INFECTIOUS DISEASES (2009)
Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration
Ravindra K. Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Class-sparing regimens for initial treatment of HIV-1 infection
Sharon A. Riddler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations
Roger Paredes et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients
M Wirden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection
SG Deeks et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
TB Campbell et al.
CLINICAL INFECTIOUS DISEASES (2005)
Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase
KKA Van Rompay et al.
JOURNAL OF VIROLOGY (2002)
分享论文
